Chiron Real Estate, Inc. (XRN)

NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-10-23

$30.00-0.53%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Chiron Real Estate, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	34.97M
EPS	—	-0.394
Annual ending 2026-12-31
Revenue	—	145.98M
EPS	—	2.996
Annual ending 2027-12-31
Revenue	—	143.15M
EPS	—	-2.01

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Complete acquisition of The Landing Alexandria for $130 million	Chiron bought a senior housing community for $130 million.	Intact	Acquisition not completed or cost deviates materially from $130 million	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Core FFO per share near $4.38 in 2026	The company aims for Core FFO per share near $4.38 in 2026.	Intact	Core FFO per share falls below $4.30 in 2026	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Raise $100 million by issuing 1,000,000 shares of Series C Preferred Stock	It raised $100 million by selling preferred stock.	Under Pressure	Preferred stock issuance falls short of 1,000,000 shares or $100 million	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenueUnavailable

$0.16B → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	Unavailable	$155,382,330	2 / 6
2026-07-25	Unavailable	$155,382,330	2 / 6
2026-07-26	Unavailable	$155,382,330	2 / 6
2026-07-27	Unavailable	$155,382,330	2 / 6
2026-07-28	Unavailable	$155,382,330	2 / 6
2026-07-29	Unavailable	Unavailable	1 / 4
2026-07-30	Unavailable	Unavailable	1 / 4
2026-07-31	Unavailable	$155,382,330	2 / 6
2026-08-01	Unavailable	Unavailable	1 / 4
2026-08-02	Unavailable	Unavailable	1 / 4
2026-08-03	Unavailable	$155,382,330	2 / 6
2026-08-04	Unavailable	$155,382,330	2 / 6
2026-08-05	Unavailable	$155,382,330	2 / 6
2026-08-06	Unavailable	Unavailable	1 / 4
2026-08-08	Unavailable	Unavailable	1 / 4
2026-08-09	Unavailable	Unavailable	1 / 4
2026-08-10	Unavailable	Unavailable	1 / 4
2026-08-12	Unavailable	$155,729,600	2 / 5
2026-08-13	Unavailable	$155,729,600	2 / 5
2026-08-14	Unavailable	Unavailable	1 / 4
2026-08-15	Unavailable	Unavailable	1 / 4
2026-08-16	Unavailable	Unavailable	1 / 4
2026-08-17	Unavailable	Unavailable	1 / 4
2026-08-18	Unavailable	Unavailable	1 / 4
2026-08-19	Unavailable	Unavailable	1 / 4
2026-08-20	Unavailable	Unavailable	1 / 4
2026-08-21	Unavailable	Unavailable	1 / 4
2026-08-22	Unavailable	Unavailable	1 / 4
2026-08-23	Unavailable	Unavailable	1 / 4
2026-08-24	Unavailable	Unavailable	1 / 4
2026-08-25	Unavailable	Unavailable	1 / 4
2026-08-26	Unavailable	Unavailable	1 / 4
2026-08-27	Unavailable	Unavailable	1 / 4
2026-08-28	Unavailable	Unavailable	1 / 4
2026-08-29	Unavailable	Unavailable	1 / 4
2026-08-30	Unavailable	Unavailable	1 / 4
2026-08-31	Unavailable	Unavailable	1 / 4
2026-09-01	Unavailable	Unavailable	1 / 4
2026-09-02	Unavailable	Unavailable	1 / 4
2026-09-03	Unavailable	Unavailable	1 / 4
2026-09-04	Unavailable	Unavailable	1 / 4
2026-09-05	Unavailable	Unavailable	1 / 4
2026-09-06	Unavailable	Unavailable	1 / 4
2026-09-07	Unavailable	Unavailable	1 / 4
2026-09-08	Unavailable	Unavailable	1 / 4
2026-09-09	Unavailable	Unavailable	1 / 4
2026-09-10	Unavailable	Unavailable	1 / 4
2026-09-11	Unavailable	Unavailable	1 / 4
2026-09-12	Unavailable	Unavailable	1 / 4
2026-09-13	Unavailable	Unavailable	1 / 4
2026-09-14	Unavailable	Unavailable	1 / 4
2026-09-15	Unavailable	Unavailable	1 / 4
2026-09-16	Unavailable	Unavailable	1 / 4
2026-09-17	Unavailable	Unavailable	1 / 4
2026-09-18	Unavailable	Unavailable	1 / 4
2026-09-19	Unavailable	Unavailable	1 / 4
2026-09-20	Unavailable	Unavailable	1 / 4
2026-09-21	Unavailable	Unavailable	1 / 4
2026-09-22	Unavailable	Unavailable	1 / 4
2026-09-23	Unavailable	Unavailable	1 / 4
2026-09-24	Unavailable	$142,020,000	1 / 5
2026-09-25	Unavailable	$142,020,000	1 / 5
2026-09-26	Unavailable	$142,020,000	1 / 5
2026-09-27	Unavailable	$142,020,000	1 / 5
2026-09-28	Unavailable	$142,020,000	1 / 5
2026-09-29	Unavailable	$142,020,000	1 / 5
2026-09-30	Unavailable	$142,020,000	1 / 5
2026-10-01	Unavailable	$142,020,000	1 / 5
2026-10-02	Unavailable	$142,020,000	1 / 5
2026-10-03	Unavailable	$142,020,000	1 / 5
2026-10-04	Unavailable	$142,020,000	1 / 5
2026-10-05	Unavailable	$142,020,000	1 / 5
2026-10-06	Unavailable	$142,020,000	1 / 5
2026-10-07	Unavailable	$142,020,000	1 / 5
2026-10-08	Unavailable	$142,020,000	1 / 5
2026-10-09	Unavailable	$142,020,000	1 / 5
2026-10-10	Unavailable	$142,020,000	1 / 5
2026-10-11	Unavailable	$143,145,375	2 / 5
2026-10-12	Unavailable	$143,145,375	2 / 5
2026-10-13	Unavailable	$143,145,375	2 / 5
2026-10-14	Unavailable	$143,145,375	2 / 5
2026-10-15	Unavailable	$143,145,375	2 / 5
2026-10-16	Unavailable	$143,145,375	2 / 5
2026-10-17	Unavailable	$143,145,375	2 / 5
2026-10-18	Unavailable	$143,145,375	2 / 5
2026-10-19	Unavailable	$143,145,375	2 / 5
2026-10-20	Unavailable	Unavailable	2 / 4
2026-10-21	Unavailable	Unavailable	2 / 4
2026-10-22	Unavailable	Unavailable	2 / 4
2026-10-23	Unavailable	Unavailable	2 / 4
2026-10-24	Unavailable	Unavailable	2 / 4

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	5	5
2026-06-01	4	6
2026-07-01	4	6
2026-08-01	4	6
2026-09-01	5	6
2026-10-01	6	6

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Complete acquisition of The Landing Alexandria for $130 millionDirect metric needs a verified mapping
Core FFO per share near $4.38 in 2026Direct metric needs a verified mapping
Raise $100 million by issuing 1,000,000 shares of Series C Preferred StockPublished status: Under Pressure

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.9%Typical daily move · historical

Downside history

-24.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Chiron Real Estate, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

XRN is an acquisition-led real estate growth story, with robust earnings quality but volatile management execution. Management is on track with portfolio expansion and capital raising, while the overall thesis state remains insufficient because recent financial history is too limited.

What's priced into Chiron Real Estate, Inc.

The evidence labels XRN cheap versus peers, though the valuation model has low confidence. The priced-in tag is justified and fragility is low, but the expectations gap is negative, indicating some tension between current expectations and the valuation case.

What the fundamentals likely do

Near term, acquisitions and property sales are expanding and reshaping the portfolio, while revenue rose modestly from the first to the second quarter of 2026. Earnings quality is robust, but recent quarter misses and a 51% estimated miss probability make the next results a key risk; guidance cuts would add pressure to the business outlook.

What Chiron Real Estate, Inc. hinges on

The multi-year view depends on whether acquisitions and capital deployment translate into stronger operating results without weaker guidance. Near-term sector conditions also matter: Fed rate cuts and continued strong results from sector peers could support the backdrop, while weaker peer trends or a guidance cut would challenge the thesis.